STRONG-AYA The Strong-aya Initiative: Improving the Future of Young Adults with Cancer
- Coordinator
- Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Netherlands
- Runs
- 1 October 2022 to 30 September 2027
- Status
- Running
- EU funding
- €7.2m
- Total cost
- €7.3m
- Partners
- 15 organisations in 7 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057482
What the project is doing
In the project's own words, from its summary on CORDIS.
STRONG-AYA is a new, interdisciplinary, multi-stakeholder European network to improve healthcare services, research and outcomes for Adolescents and Young Adults (AYA) with cancer, defined as individuals aged 15-39 years at cancer diagnosis. AYAs with cancer form a unique group; they face age-specific issues (e.g. infertility, unemployment, financial problems) and decreased quality of life due to cancer and its treatment.
Unlike dedicated healthcare and trials for pediatric cancer patients, AYA-specific healthcare services are scarce and vary across Europe. AYAs who are at the core of society and economy need access to age-adjusted and high-quality healthcare. AYA-care and research will benefit from collection and pooling of patient-centered data and collaboration among all stakeholders: patients, healthcare professionals, scientists, and policymakers.
Our consortium of clinical and scientific leaders in AYA-care, data science and registries, European Cancer Organisation, Youth Cancer Europe and EORTC will build on previous initiatives and EU grants. Within STRONG-AYA we will set up a value-based healthcare research ecosystem to develop data-driven, interactive policy and visualization tools that bring, in co-creation with all stakeholders including patients, novel insights into AYA healthcare.
The project objectives, include: 1) Development of a Core Outcome Set (COS) for AYAs with cancer; 2) Implementation of the COS in 5 national healthcare systems (FR, IT, NL, UK, PL) and establish national infrastructures for outcome data management and clinical decision-making and a pan-European ecosystem that also welcomes future European countries; 3) Disseminate outcomes and facilitate interactions between national and pan-European stakeholders to develop data-driven analysis tools to process and present relevant outcomes, establish feedback loops for AYA cancer patients and the healthcare systems, and improve the reporting and assessment of outputs towards policy-makers.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | Amsterdam | Netherlands | Coordinator |
| European Cancer Organisation | Bruxelles / Brussel | Belgium | Participant |
| Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer Aisbl | Bruxelles / Brussel | Belgium | Participant |
| Centre De Lutte Contre Le Cancer Leon Berard | Lyon | France | Participant |
| Institut Gustave Roussy | Villejuif | France | Participant |
| Fondazione Irccs Istituto Nazionale Dei Tumori | Milan | Italy | Participant |
| Ffund BV | Abcoude | Netherlands | Participant |
| Stichting Integraal Kankercentrum Nederland | Utrecht | Netherlands | Participant |
| Universiteit Maastricht | Maastricht | Netherlands | Participant |
| Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy | Warszawa | Poland | Participant |
| Fundatia Youth Cancer Europe | Cluj Napoca | Romania | Participant |
| The Leeds Teaching Hospitals National Health Service Trust | Leeds | United Kingdom | Associatedpartner |
| The University of Manchester | Manchester | United Kingdom | Associatedpartner |
| University of Leeds | Leeds | United Kingdom | Associatedpartner |
| University of Southampton | Southampton | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI